After medical device M&A picked up last year, 2026 is off to a busy start. Boston Scientific’s planned $14.5 billion acquisition of Penumbra, a company that makes thrombectomy and embolization devices, was the largest purchase so far this year.
In another multibillion-dollar deal, Danaher announced plans this month to buy patient monitoring firm Masimo.
Several medtech firms have also announced major divestitures in the past year. Some notable ones to watch include BD’s planned $17.5 billion sale of its biosciences and diagnostics businesses, Medtronic’s planned spinoff of its diabetes business into a publicly traded company, and Johnson &Johnson’s planned divestiture of its orthopedics segment.
Here are the top M&A deals so far this year:
